Safety and efficacy of switching to DTG plus 3TC regimen from a LPV/ R +TDF+3TC based second line regimen: a real world study from China with extensive experience in the use of LPV/r and TDF regimens (abridged edition)

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2020
This article has no abstract
Epistemonikos ID: cb76f320fedef94370719bf94b730e29d62af66a
First added on: Apr 07, 2025